CHLORPROPAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorpropamide, and when can generic versions of Chlorpropamide launch?
Chlorpropamide is a drug marketed by Ani Pharms, Dava Pharms Inc, Halsey, Mylan, Par Pharm, Rising, Sandoz, Superpharm, Usl Pharma, Watson Labs, and Watson Labs Teva. and is included in thirty-one NDAs.
The generic ingredient in CHLORPROPAMIDE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.
Summary for CHLORPROPAMIDE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 31 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 5 |
Patent Applications: | 3,633 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLORPROPAMIDE at DailyMed |
Recent Clinical Trials for CHLORPROPAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Drug Safety and Effectiveness Network, Canada | |
Canadian Institutes of Health Research (CIHR) | |
Canadian Network for Observational Drug Effect Studies, CNODES |